Aveanna Healthcare Holdings Inc. · NASDAQ:AVAH
Aveanna Healthcare — Investor Presentation (September 2025)
31 slides from Aveanna Healthcare's investor presentation, Sep 29, 2025
Slide 1: Investor Presentation September 2025
Investor Presentation September 2025 Exhibit 99.1
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase a
Slide 3: Non-GAAP Financial Measures
Non-GAAP Financial Measures In addition to our results of operations prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”), we also evaluate our financial performance using EBITDA, Adjusted EBITDA, Field contribution and Field contribution margin, Free cash flow, an
Slide 4: Contents
Contents Introduction 5 Company Overview 8 Financial Overview 24 Appendix 28
Slide 5: Introduction
aveanna healthcare: |. Introduction ———,
Slide 6: Transforming the Value of Homecare
Transforming the Value of Homecare Aveanna offers a leading, diversified homecare platform that delivers innovative care to pediatric, adult, and geriatric patients. With locations in 38 states, Aveanna has established a national footprint dedicated to high-quality clinical outcomes and enhanced val
Slide 7: Management Team
Debbie Stewart Principal Accounting Officer Jeff Shaner Chief Executive Officer CEO of Aveanna since 2023 Instrumental in formation of Aveanna Healthcare Chief Operating Officer of Aveanna Healthcare since 2017 Chief Operating Officer of PSA Healthcare since 2015 Former SVP, President of Operations
Slide 8: Company Overview
8 aveanna healthcare: ll. Company Overview
Slide 9: Aveanna Overview
Aveanna Overview ___________________________ 1. Guidance metrics are as of the end of Q2 2025. Adjusted EBITDA is a non-GAAP financial measure. See Appendix for a reconciliation to the most comparable GAAP measure. The Company does not provide guidance on net income, or a reconciliation of Adjusted
Slide 10: The Premier National Pediatric and Geriatric Nursing Platform
The Premier National Pediatric and Geriatric Nursing Platform 38 States 366 Locations 29K Caregivers 88 Preferred Payors 43.9m Homecare Hours(1) ___________________________ 1. YTD PDS Hours Annualized
Slide 11: Aveanna's Transformative Homecare Platform
Melia and Mom Heather Valerie Aveanna's Transformative Homecare Platform Preferred Payor Partnerships Government Affairs Strategy Scaled National Platform Technology and Data Driven Results Reduction in Total Cost of Care Our advanced homecare platform positions us to improve outcomes with data-driv
Slide 12: Preferred Payor Strategy Has Driven Outsized Performance
Preferred Payor Strategy Has Driven Outsized Performance PDS Preferred Payors State Rate Increases Home Health Episodic Mix Value-based Agreements Continued substantial progress as demonstrated by key performance metrics. (1) ___________________________ 1. See Disclaimers and Forward-looking Stateme
Slide 13: Future Opportunity and Long-term Growth Rate
Melia and Mom Heather Valerie Our future opportunity will continue to provide enhanced value that is driven by our significant investment in our value-based national homecare platform. Aveanna's Transformative Homecare Platform Value-based Organic Growth Risk-based Growth Core Organic Growth Scaled
Slide 14: Differentiated Growth, Diversification and Scale vs. Public Peers
Differentiated Growth, Diversification and Scale vs. Public Peers ___________________________ Source: Capital IQ and Wall Street research as of September 23, 2025 1. Amedisys is no longer publicly traded as of August 14,2025 2. Represents YTD Q2 2025 3. Represents total Non-Medicare Fee for Services
Slide 15: Fragmented Home Care Markets Support Sustainable Growth
Fragmented Home Care Markets Support Sustainable Growth $20bn Legacy Pediatric Focus Personal Care $18.0bn Annual U.S. Healthcare Spend $4.5tn Therapy $6.0bn Enteral Nutrition $3.0bn Therapy $7.0bn Private Duty Nursing $10.0bn Hospice $23.0bn $99bn Addressable Adult Opportunity TAM annual growth fro
Slide 16: Impacts of the One Big Beautiful Bill
Impacts of the One Big Beautiful Bill The Congressional Budget Office projects OBBBA will result in a reduction to federal Medicaid spending by an estimated $1.15 trillion over the next 10 years The OBBBA changes to Medicaid include provisions expected to reduce the population of Medicaid recipients
Slide 17: Consistent Track Record of EBITDA Expansion and Performance
Consistent Track Record of EBITDA Expansion and Performance 2023A – 2025A Quarterly Adjusted EBITDA Beat / (Miss) ~18% ~69% ~35% ~18% ~7% ~8% ~17% ~23% ~23% ~83% ___________________________ Source: Capital IQ and Public Filings. 1. Beat / (Miss) indicates performance relative to consensus estimates.
Slide 18: Focused Approach to Continued De-Levering
Focused Approach to Continued De-Levering >5x Deleveraging in 3 years Total Net Leverage(1) ___________________________ Note: Includes securitization. 1. Net Leverage is a non-GAAP financial measure. See Appendix for a reconciliation to the most comparable GAAP measure.
Slide 19: Aveanna Business Segments
Medical Solutions Home Health & Hospice Aveanna Business Segments Home Health Geriatric Patient Population Intermittent Services at Home Shorter Length of Stay Patients Value-based Care Component Hospice Geriatric Patient Population Per Diem Reimbursement End-of-life Care / Support Median Length of
Slide 20: Private Duty Services Segment
Gross Margin Revenue % Margin Private Duty Services Segment Financial Highlights and Targets Key Operating Statistics $1,892m Net Revenue1 26% – 28% Target Gross Margin2 3% – 5% Target Organic Growth Rate3 257 Locations 29 States 39,000 Patients on Service 55% % of PP Volume Preferred Payors 25 Pref
Slide 21: Home Health & Hospice Segment
Home Health & Hospice Segment ___________________________ 1. YTD 2025 revenue annualized. 2. Management’s target for gross margin percentages over time. 3. Management’s target for total organic revenue growth rate over time. HH Preferred Payors defined as episodic agreements Caregiver Capacity align
Slide 22: Medical Solutions Segment
Medical Solutions Segment ___________________________ 1. YTD 2025 revenue annualized. 2. Management’s target for gross margin percentages over time. 3. Management’s target for total organic revenue growth rate over time. Preferred Payor Contracts provide in-network patient support at favorable rates
Slide 23: Scaled Platform Built for Driving Growth and Enhancing Value
Scaled Platform Built for Driving Growth and Enhancing Value
Slide 24: Financial Overview
8 aveanna healthcare: Ill. Financial Overview 24
Slide 25: Q2 2025 Financial Performance: Summary Results
Q2 2025 Financial Performance: Summary Results PDS Q2 2025 revenue growth of 19.2% from Q2 2024, driven by 11.1 million hours of care or 6.9% YOY volume increase MS Q2 2025 gross margin growth of 10.0% from Q2 2024, driven by modernization efforts HHH Q2 2025 revenue growth of 10.0% from Q2 2024, dr
Slide 26: Financial Performance: Capital Structure
Financial Performance: Capital Structure Liquidity of $456.9m, comprised of the following: $100.7m cash on balance sheet $250.0m revolver availability $106.2m securitization availability Undrawn revolver at the end of Q2 $23m in outstanding letters of credit at the end of Q2 Total variable rate debt
Slide 27: Path Forward: Strategic and Operational Focus on Driving Shareholder Value
Path Forward: Strategic and Operational Focus on Driving Shareholder Value Value-based Growth Enhanced Capital Structure Core Organic Growth
Slide 28: Appendix
8 aveanna healthcare: IV. Appendix 28
Slide 29: Reconciliation of Net Income to Adjusted EBITDA
Reconciliation of Net Income to Adjusted EBITDA ___________________________ 1-7 and A: Please see our financial filings (10K, 10Q) for 2023, 2024, and Q2 2025 for further description of the nature of these items
Slide 30: Net Leverage Reconciliation
Net Leverage Reconciliation
Slide 31: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
Aveanna Healthcare Holdings — Investor Presentation (September 2025) on 6ix